© 2021 MJH Life Sciences and Contemporary Pediatrics. All rights reserved.
© 2021 MJH Life Sciences™ and Contemporary Pediatrics. All rights reserved.
September 09, 2021
The European Commission has granted an expanded approval to ravulizumab-cwvz to include children with a body weight of at least 10 kg, as well as adolescents, with paroxysmal nocturnal hemoglobinuria.